Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nissim Hay

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|May 21, 2010
Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4Peifeng Li, Shankar Jayarama, Lakshmy Ganesh, et al.
Nature Medicine|October 18, 2005
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivoJuhua Chen, Payaningal R Somanath, Olga Razorenova, et al.
The Journal of Clinical Investigation|March 20, 2014
Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammationJing Li, Kyungho Kim, Eunsil Hahm, et al.
Journal of Cellular Biochemistry|September 17, 2013
MADD is a downstream target of PTEN in triggering apoptosisShankar Jayarama, Liang-Cheng Li, Lakshmy Ganesh, et al.
Molecular and Cellular Biology|July 22, 2009
mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibitionPrashanth T Bhaskar, Veronique Nogueira, Krushna C Patra, et al.
Digestive Diseases and Sciences|September 4, 2007
Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver diseaseScott J Cotler, Nissim Hay, Hui Xie, et al.
Developmental Cell|April 24, 2010
FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and RictorChia-Chen Chen, Sang-Min Jeon, Prashanth T Bhaskar, et al.
Cancer Cell|December 9, 2008
Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosisVeronique Nogueira, Youngkyu Park, Chia-Chen Chen, et al.
Digestive Diseases and Sciences|November 9, 2014
Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinomaGrace Guzman, Rohini Chennuri, Alexander Chan, et al.
The Journal of Biological Chemistry|December 17, 2008
Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cellsMohd Minhajuddin, Kaiser M Bijli, Fabeha Fazal, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|May 21, 2010
Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4Peifeng Li, Shankar Jayarama, Lakshmy Ganesh, et al.
Nature Medicine|October 18, 2005
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivoJuhua Chen, Payaningal R Somanath, Olga Razorenova, et al.
The Journal of Clinical Investigation|March 20, 2014
Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammationJing Li, Kyungho Kim, Eunsil Hahm, et al.
Journal of Cellular Biochemistry|September 17, 2013
MADD is a downstream target of PTEN in triggering apoptosisShankar Jayarama, Liang-Cheng Li, Lakshmy Ganesh, et al.
Molecular and Cellular Biology|July 22, 2009
mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibitionPrashanth T Bhaskar, Veronique Nogueira, Krushna C Patra, et al.
Digestive Diseases and Sciences|September 4, 2007
Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver diseaseScott J Cotler, Nissim Hay, Hui Xie, et al.
Developmental Cell|April 24, 2010
FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and RictorChia-Chen Chen, Sang-Min Jeon, Prashanth T Bhaskar, et al.
Cancer Cell|December 9, 2008
Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosisVeronique Nogueira, Youngkyu Park, Chia-Chen Chen, et al.
Digestive Diseases and Sciences|November 9, 2014
Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinomaGrace Guzman, Rohini Chennuri, Alexander Chan, et al.
The Journal of Biological Chemistry|December 17, 2008
Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cellsMohd Minhajuddin, Kaiser M Bijli, Fabeha Fazal, et al.
Pageof 12